NeOnc Technologies Holdings is trading at $2.56, down 5.72% during the October 8 session, reversing its reported 8.5% pre-market gain; no clear company-specific catalyst has been identified for the drop.

  • The biotech sector is also weaker, with XBI down 2.04%; thin liquidity can amplify moves in this micro-cap stock.
  • Recent company coverage concerns previously reported clinical results and planned FDA discussions, not a new October 8 announcement.